Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

NCT00003809 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

NETWORK

Sponsor class

Conditions

Head and Neck Cancer

Interventions

BIOLOGICAL: cetuximab
DRUG: cisplatin

Sponsor

Eastern Cooperative Oncology Group

Collaborators

[object Object]